Efficacy of Empagliflozin in the Treatment of Experimental Myocardial Infarction
Introduction. With the emergence of empagliflozin in the pharmaceutical market, there has been an increase in publications on the primary and secondary pharmacodynamics of the drug, and the list of potential indications for the use of this sodium-glucose co-transporter inhibitor is increasing. Hypot...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Russo |
| Baskı/Yayın Bilgisi: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2023-12-01
|
| Seri Bilgileri: | Разработка и регистрация лекарственных средств |
| Konular: | |
| Online Erişim: | https://www.pharmjournal.ru/jour/article/view/1640 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|